BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alqifari SF, Alkomi O, Esmail A, Alkhawami K, Yousri S, Muqresh MA, Alharbi N, Khojah AA, Aljabri A, Allahham A, Prabahar K, Alshareef H, Aldhaeefi M, Alrasheed T, Alrabiah A, AlBishi LA. Practical guide: Glucagon-like peptide-1 and dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonists in diabetes mellitus. World J Diabetes 2024; 15(3): 331-347 [PMID: 38591071 DOI: 10.4239/wjd.v15.i3.331]
URL: https://www.wjgnet.com/1948-9358/full/v15/i3/331.htm
Number Citing Articles
1
V. V. Salukhov, G. R. Galstyan, Iu. Sh. Khalimov, I. G. Bakulin, D. V. Cherkashin, F. E. Shadrichev, N. A. Sukhotskaia. Practical application of semaglutide: From evidence-based research to expert decisionsMeditsinskiy sovet = Medical Council 2025; (6): 14 doi: 10.21518/ms2025-185
2
Krishna S. Upadhye, Hariom Patidar, Narendra Bamnia, Narendra Yadav. HbA1c reduction strategies: An overview of pharmacological interventionsNational Journal of Pharmacology and Therapeutics 2025; 3(1): 24 doi: 10.4103/NJPT.NJPT_72_24
3
Paulo César Gete Palacios, Alberto Moscona-Nissan, Renata Saucedo, Aldo Ferreira-Hermosillo. Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with InfertilityMetabolites 2025; 15(4): 260 doi: 10.3390/metabo15040260
4
Michael Horowitz, Lu Cai, Md Shahidul Islam. Glucagon-like-peptide-1 receptor agonists and the management of type 2 diabetes-backwards and forwardsWorld Journal of Diabetes 2024; 15(3): 326-330 doi: 10.4239/wjd.v15.i3.326